PATENT CLAIM ANALYSIS

Application Number: 16154301
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "254020"]

Abstract:
A compound having formula IA is useful for treating a neurodegenerative disease: or a pharmaceutically acceptable salt or ester thereof, where R 0 , R 1 , R 2 , R 7 , R 8  are delineated substituents; A 1  is a C 6-12  aryl group, C 5-12  heteroaryl group, substituted 3-hydroxypyridin-4(1H)-one, with i hydrogen atoms replaced with R 7  and j hydrogen atoms replaced with R 8 ; p is an integer from 1 to 6; X 1 , Y 1  are each independently CH or N; M is absent or a divalent linking moiety in which Z is repeated m times; m is an integer from 0 to 5; i, j are each independently 0, 1, 2, or 3; and o is 0, 1, 2, 3, or 4.

Claim (Index 4):
The compound of claim I wherein A 1  is:

Metadata:
- Claim Count in Document: 12.0
- Percentile: 97.0
- Lexical Diversity: 1.97436
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14648413', '13264505', '15187656', '14580045', '13646143']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8253832783158562
- 35 USC 102 Novelty (BERT): 0.5596200179936017
- Combined Prediction Score: 0.7988069522836307
- Mean Citation Score: 385.281352
- Max Citation Score: 493.7687
- Similarity Product: 301.7411785426676

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test